18221 Investors following Aurobindo Pharm. Share this News with them.
0
Like this story, share it with millions of investors on M3
Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30mg from the US Food & Drug Administration
Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30mg from the US Food & Drug Administration (USFDA).
The New Drug Application (NDA) 22-295 provides for the use of Abacavir Sulfate / Lamivudine Tablets 60/30mg for the treatment of HIV infections.
The company had earlier received tentative approvals to Co-Packaged Lamivudine / Zidovudine Tablets + Abacavir Sulfate Tablets 150/300mg + 300mg and Abacavir Sulfate / Lamivudine Tablets 600/300 mg
This is Aurobindo's 87th ANDA approval from USFDA (61 Final approvals, 26 Tentative approvals).
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Tata Steel | BSE Sensex | Commodities | Aurobindo Pharma | Namma Metro | Mahindra Satyam | Iran | Reliance Industries | Vodafone Essar 
